Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma: Comment. | Asian Pac J Cancer Prev;25(6): 1861-1862, 2024 Jun 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma: Comment.

Daungsupawong, Hinpetch; Wiwanitkit, Viroj.

Affiliation

Daungsupawong H; Private Academic Consultant, Phonhong, Lao People's Democratic Republic, Laos.
Wiwanitkit V; University Centre for Research and Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India.

Asian Pac J Cancer Prev ; 25(6): 1861-1862, 2024 Jun 01.

Article in En | MEDLINE | ID: mdl-38918644

Subject(s)
Key words

Chemotherapy; Genotype; cancer

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Vincristine / Cytochrome P-450 CYP3A Limits: Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Vincristine / Cytochrome P-450 CYP3A Limits: Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication: